智通财经APP获悉，亿胜生物科技(01061)涨幅扩大逾17%，截至发稿，涨15.79%，报3.3港元，成交额4525.81万港元。
消息面上，亿胜生物科技发布年度财报，营业额16.7亿元，同比下降3.9%。录得纯利3.07亿元，增长11.6%，每股盈利54.14港仙。末期息6港仙。连中期息全年共派12港仙，增派3港仙。
据悉，集团的旗舰生物药贝复舒系列及贝复济系列继续成为主要增长动力，占总营业额的84.5%。眼科分部的营业额为7.72亿港元，同比增长2.2%，得益于市场对眼部护理产品的强劲需求。外科分部录得8.80亿港元的收入，由于受政策影响同比减少9.3%，但仍然为业绩贡献的重要支柱。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.